DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/78xcv4/pharmaceuticals) has announced the addition of the "Pharmaceuticals & Healthcare Q115 Round-Up" report to their offering.
Governments in both developed and emerging markets will increasingly adopt medicine cost containment mechanisms.
In the wake of the global financial crisis, these approaches have proved successful in limiting pharmaceutical expenditure, which has been supported by a growing disease burden and the introduction of more innovative mechanisms.
The global pharmaceutical market is set to post a compound annual growth rate of 3.0% over the next five years. Combined sales of prescription drugs and over-the-counter medicines increased from USD1,094bn in 2013 to USD1,122bn in 2014, representing year-on-year (y-o-y) growth of 2.4%.
Due to the strong US dollar and weak currencies in emerging markets, the global pharmaceutical market will contract in 2015 - although it will expand in local currency terms. Through to 2019, all regions will experience healthy growth, with the exception of Western Europe.
Key Topics Covered:
1. Industry View
2. SWOT
3. Industry Forecasts
4. Macroeconomic Forecasts
5. Industry Risk Reward Index
6. Market Overview
7. Industry Trends & Developments
8. Regulatory Developments
9. Competitive Landscape
10. Methodology
For more information visit http://www.researchandmarkets.com/research/78xcv4/pharmaceuticals
